Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis
Open accessThe DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The purpose of this review is to examine the effect of Omega-3 Fatty acids on mortality, morbidity, and adverse events in patients with acute myocardial infarction (AMI). METHODS: Data Sources: MEDLINE, EMBASE, and the Cochrane Library through May 2018. STUDY SELECTION: Randomized Controlled trials (RCT). Certainty of evidence was assessed with the GRADE system. INTERVENTIONS: omega 3 fatty acids against placebo or no treatment. Primary and secondary outcomes: All-cause death, cardiovascular death, new AMI, stroke, need for therapeutic angioplasty or By-pass, new diagnosis of cancer and incidence of adverse events. RESULTS: For the efficacy endpoints we included 10 RCT (24,414 patients). Omega 3 fatty acids probably make little or no difference to all-cause mortality (4 studies 9141 patients RR 1.06 - CI95% 0.90 to 1.27, moderate certainty), cardiovascular mortality (3 studies 4304 patients RR 0.93 - CI95% 0.63 to 1.37, moderate certainty), new AMI (RR 1.24 CI95% 0.71 to 2.14 - moderate certainty), any cardiovascular event (RR 0.95 95%CI 0.86 to 1.05; low certainty due to risk of bias and imprecision), and stroke (RR 1.2 95%CCI 0,66-2,19 - moderate certainty). Regarding adverse events, we are uncertain if Omega 3 fatty acids improve/reduce non severe adverse events (RR 1.39 95% CI 0.36 to 5.34; very low certainty). There is probably little or no difference in the outcome suspension due to adverse events (RR 1.19 CI 95% 0.97 to 1.47; moderate certainty). CONCLUSIONS: For adult patients with AMI, omega 3 fatty-acids probably yield no benefit to patient important outcomes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures









Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Combinations of statins with fibrates, niacin, or fish oil have thus far generally failed to demonstrate cardiovascular benefits beyond that achieved with statins alone.128–132”
From Clinical management of stable coronary artery disease in patients with type 2 diabetes mellitus: a scientific statement from the American Heart Association (2020) · cites this paper as [132]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The National Center for Biotechnology Information
Benson, D., Boguski, M., Lipman, D. J., & Ostell, J. (1990) · Genomics · doi:10.1016/0888-7543(90)90583-g · Cited by 5,126
What is ‘quality of evidence’ and why is it important to clinicians?
Guyatt, G. H., Oxman, A. D., Kunz, R., Vist, G. E., Falck-Ytter, Y., & Schünemann, H. J. (2008) · BMJ · doi:10.1136/bmj.39490.551019.be · Cited by 3,250
de Lorgeril, M., Salen, P., Martin, J.-L., Monjaud, I., Delaye, J., & Mamelle, N. (1999) · Circulation · doi:10.1161/01.cir.99.6.779 · Cited by 2,910
GRADE guidelines 6. Rating the quality of evidence—imprecision
Guyatt, G. H., Oxman, A. D., Kunz, R., Brozek, J., Alonso-Coello, P., Rind, D., Devereaux, P. J., Montori, V. M., Freyschuss, B., Vist, G., et al. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2011.01.012 · Cited by 2,693
Burr, M. L., Gilbert, J. F., Holliday, R. M., Elwood, P. C., Fehily, A. M., Rogers, S., Sweetnam, P. M., & Deadman, N. M. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90828-3 · Cited by 2,610
Yokoyama, M., Origasa, H., Matsuzaki, M., Matsuzawa, Y., Saito, Y., Ishikawa, Y., Oikawa, S., Sasaki, J., Hishida, H., Itakura, H., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60527-3 · Cited by 2,516
Smith, S. C., Allen, J., Blair, S. N., Bonow, R. O., Brass, L. M., Fonarow, G. C., Grundy, S. M., Hiratzka, L., Jones, D., Krumholz, H. M., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.174516 · Cited by 2,104
GISSI-HF investigators (2008) · The Lancet · doi:10.1016/s0140-6736(08)61239-8 · Cited by 1,350
The Composition of Food Consumed by Greenland Eskimos
Bang, H. O., Dyerberg, J., & Hjørne, N. (1976) · Acta Medica Scandinavica · doi:10.1111/j.0954-6820.1976.tb08198.x · Cited by 944
n–3 Fatty Acids and Cardiovascular Events after Myocardial Infarction
Kromhout, D., Giltay, E. J., & Geleijnse, J. M. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003603 · Cited by 936
Research works printed but not linked: 7
- Foundation., B.N n-3 fatty acids and health: briefing paper 1999 London British Nutrition Foundation
- University, C.G.a.M Tools to assess risk of bias in cohort and case control studies; randomized controlled trials; and longitudinal symptom research studies aimed at the general population 2013
- Schünemann H Brożek J Guyatt G Oxman A GRADE handbook for grading quality of evidence and strength of recommendations 2013
- National Center for Biotechnology Information. PubChem Compound Database; CID=5280934. https://pubchem.ncbi.nlm.nih.gov/compound/5280934. Accessed 5 May 2019.
- UK., F.S.A., Dioxins and PCBs in the UK diet: 1997 Total diet study samples. Food Surveillance Information Sheet. 2000(Vol. 4/00. [ FSIS 4/00]).
- MacLean CH Newbery SJ Mujica WA Issa A Khanna P Lim YW Effects of omega-3 fatty acids on cancer. Evidence Report/Technology Assessment 2005 Rockville (MD) Agency for Healthcare Research and Quality E010 E012
- National Clinical Guideline, C. Myocardial infarction: cardiac rehabilitation and prevention of further MI NICE guidelines [CG172]. 2013. 31891465
Cited by
Arnold, S. V., Bhatt, D. L., Barsness, G. W., Beatty, A. L., Deedwania, P. C., Inzucchi, S. E., Kosiborod, M., Leiter, L. A., Lipska, K. J., Newman, J. D., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000766 · Cited by 304
Piccinin, E., Cariello, M., De Santis, S., Ducheix, S., Sabbà, C., Ntambi, J. M., & Moschetta, A. (2019) · Nutrients · doi:10.3390/nu11102283 · Cited by 186
Shen, S., Gong, C., Jin, K., Zhou, L., Xiao, Y., & Ma, L. (2022) · Frontiers in Nutrition · doi:10.3389/fnut.2022.809311 · Cited by 59
Yu, F., Qi, S., Ji, Y., Wang, X., Fang, S., & Cao, R. (2022) · Medicine · doi:10.1097/md.0000000000029556 · Cited by 23
“[33] The THIS-DIET trial found active intervention with the Mediterranean-style diet and could provide significant benefits on cardiovascular health in patients after MI.[35] The REDUCE-IT trial found that the risk for MACEs was significantly reduced for patients with elevated triglyceride levels applied with 2 g of o…”
BackgroundInfluentialYang, B., Tseng, P.-T., Hu, X., Zeng, B.-Y., Chang, J. P.-C., Liu, Y., Chu, W.-J., Zhang, S.-S., Zhou, Z.-L., Chu, C.-S., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101196 · Cited by 21
Metadata
- Authors
- Popoff, F., Balaciano, G., Bardach, A., Comandé, D., Irazola, V., Catalano, H. N., & Izcovich, A.
- Affiliations
- Ministerio de Salud (AR)
- Hospital Alemán (AR)
- Instituto de Efectividad Clínica y Sanitaria (AR)
- Corresponding author
- Popoff, Federico
- Balaciano, Giselle
- ORCID
- Venue
- BMC Cardiovascular Disorders
- Published
- 2019-06-04
- Volume
- 19
- Issue
- 1
- Pages
- 136-136
- ISSN
- 1471-2261 (ISSN-L)
- PMC
- PMC6549284
- OpenAlex
- W2948075275
- Cited by
- 19
- References
- 40
- Citations by year
- 2025: 1 · 2024: 2 · 2023: 4 · 2022: 5 · 2021: 2 · 2020: 3 · 2019: 2
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- BMC Cardiovascular Disorders (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- CONICET Digital (CONICET) (submittedVersion, cc-by)
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
- Keywords
- omega-3 fatty acids, acute myocardial infarction, mortality, cardiovascular mortality, reinfarction, stroke, adverse events, lipid-lowering therapy, cardiovascular events
- MeSH terms
- Cause of Death, Humans, Myocardial Infarction, Recurrence, Risk Factors, Time Factors, Fatty Acids, Omega-3, Treatment Outcome, Risk Assessment, Dietary Supplements, Secondary Prevention
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis. https://app.cochat.ai/papers/10.1186/s12872-019-1086-3
- The paper
- Popoff, F., Balaciano, G., Bardach, A., Comandé, D., Irazola, V., Catalano, H. N., & Izcovich, A. (2019). Omega 3 fatty acid supplementation after myocardial infarction: a systematic review and meta-analysis. BMC Cardiovascular Disorders. https://doi.org/10.1186/s12872-019-1086-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.